Skip to content
MedsAcross

Brand family

Neupogen

Filgrastim · Amgen
United States
Presentations
4
Markets
1

Neupogen is a brand of Filgrastim marketed by Amgen, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Filgrastim
Brand owner
Amgen
Registered in
United States
Strengths and forms
300 mcg/0.5 mL injection, 300 mcg/1 mL injection, 480 mcg/0.8 mL injection, 480 mcg/1.6 mL injection

All presentations

MedicineManufacturerRegisterAvailability
Neupogen 300 mcg/0.5 mL injectionIntravenous, subcutaneous Cold chainAmgenUS FDAAvailable on request
Neupogen 300 mcg/1 mL injectionIntravenous, subcutaneous Cold chainAmgenUS FDAAvailable on request
Neupogen 480 mcg/0.8 mL injectionIntravenous, subcutaneous Cold chainAmgenUS FDAAvailable on request
Neupogen 480 mcg/1.6 mL injectionIntravenous, subcutaneous Cold chainAmgenUS FDAAvailable on request

Equivalent brands

Other brands of Filgrastim.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Neupogen

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.